Insight into the Structural Requirements of Urokinase-Type Plasminogen Activator Inhibitors Based on 3D QSAR CoMFA/CoMSIA Models

Bhoomendra A. Bhongade; Andanappa K. Gadad

doi:10.1021/jm050149r

Insight into the Structural Requirements of Urokinase-Type Plasminogen Activator Inhibitors Based on 3D QSAR CoMFA/CoMSIA Models

Journal of Medicinal Chemistry ◽

10.1021/jm050149r ◽

2006 ◽

Vol 49 (2) ◽

pp. 475-489 ◽

Cited By ~ 7

Author(s):

Bhoomendra A. Bhongade ◽

Andanappa K. Gadad

Keyword(s):

Plasminogen Activator ◽

3D Qsar ◽

Structural Requirements ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Insight Into

Download Full-text

4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/s0960-894x(02)00312-8 ◽

2002 ◽

Vol 12 (15) ◽

pp. 2023-2026 ◽

Cited By ~ 14

Author(s):

Jeffrey R Spencer ◽

Danny McGee ◽

Darin Allen ◽

Bradley A Katz ◽

Christine Luong ◽

...

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator

Download Full-text

Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites

International Journal of Gynecology & Obstetrics ◽

10.1016/0020-7292(94)90376-x ◽

1994 ◽

Vol 47 (2) ◽

pp. 195-195

Author(s):

G.E. Hofmann ◽

I. Glatstein ◽

F. Schatz ◽

D. Heller ◽

L. Deligdisch

Keyword(s):

Plasminogen Activator ◽

Immunohistochemical Localization ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Implantation Sites ◽

Early Human ◽

Human Implantation

Download Full-text

2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/s0960-894x(02)00311-6 ◽

2002 ◽

Vol 12 (15) ◽

pp. 2019-2022 ◽

Cited By ~ 21

Author(s):

Richard L. Mackman ◽

Hon C. Hui ◽

J.Guy Breitenbucher ◽

Bradley A. Katz ◽

Christine Luong ◽

...

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator

Download Full-text

3D-QSAR Studies on Isocoumarin-based Urokinase-type Plasminogen Activator (uPA) Inhibitors Employing Linear and Non-linear Regression Analysis Methods

Letters in Drug Design & Discovery ◽

10.2174/157018012803308012 ◽

2012 ◽

Vol 9 (9) ◽

pp. 874-880 ◽

Cited By ~ 1

Author(s):

Bhoomendra A. Bhongade ◽

Nikhil D. Amnerkar ◽

Sirajunisa Talath ◽

Kishore P. Bhusari ◽

Andanappa K. Gadad

Keyword(s):

Regression Analysis ◽

Linear Regression ◽

Plasminogen Activator ◽

Linear Regression Analysis ◽

3D Qsar ◽

Qsar Studies ◽

Analysis Methods ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Non Linear

Download Full-text

Is inhibition process better described with MD(QM/MM) simulations? The case of urokinase type plasminogen activator inhibitors

Journal of Computational Chemistry ◽

10.1002/jcc.21983 ◽

2012 ◽

Vol 33 (6) ◽

pp. 607-616 ◽

Cited By ~ 7

Author(s):

Florent Barbault ◽

François Maurel

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibition Process

Download Full-text

Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines†

Journal of Medicinal Chemistry ◽

10.1021/jm061066t ◽

2007 ◽

Vol 50 (10) ◽

pp. 2341-2351 ◽

Cited By ~ 38

Author(s):

Paul V. Fish ◽

Christopher G. Barber ◽

David G. Brown ◽

Richard Butt ◽

Michael G. Collis ◽

...

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator

Download Full-text

Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer?

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.06.002 ◽

2017 ◽

Vol 43 (2) ◽

pp. 252-257 ◽

Cited By ~ 7

Author(s):

P.A. van Dam ◽

A. Coelho ◽

C. Rolfo

Keyword(s):

Ovarian Cancer ◽

Maintenance Therapy ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator

Download Full-text

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

British Journal of Cancer ◽

10.1038/bjc.1994.74 ◽

1994 ◽

Vol 69 (2) ◽

pp. 398-405 ◽

Cited By ~ 104

Author(s):

C Bouchet ◽

F Spyratos ◽

PM Martin ◽

K Hacène ◽

A Gentile ◽

...

Keyword(s):

Plasminogen Activator ◽

Prognostic Value ◽

Breast Carcinomas ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Pai 1

Download Full-text

Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites

American Journal of Obstetrics and Gynecology ◽

10.1016/s0002-9378(94)70246-2 ◽

1994 ◽

Vol 170 (2) ◽

pp. 671-676 ◽

Cited By ~ 57

Author(s):

Glen E. Hofmann ◽

Isaac Glatstein ◽

Frederick Schatz ◽

Debra Heller ◽

Liana Deligdisch

Keyword(s):

Plasminogen Activator ◽

Immunohistochemical Localization ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Implantation Sites ◽

Early Human ◽

Human Implantation

Download Full-text

Urokinase-type plasminogen activator and plasminogen activator inhibitors (PAI-1 and PAI-2) in extracts of invasive cervical carcinoma and precursor lesions

European Journal of Cancer ◽

10.1016/s0959-8049(97)10038-7 ◽

1998 ◽

Vol 34 (4) ◽

pp. 566-569 ◽

Cited By ~ 27

Author(s):

A Daneri-Navarro ◽

G Macias-Lopez ◽

A Oceguera-Villanueva ◽

S Del Toro-Arreola ◽

A Bravo-Cuellar ◽

...

Keyword(s):

Plasminogen Activator ◽

Cervical Carcinoma ◽

Precursor Lesions ◽

Invasive Cervical Carcinoma ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Pai 1

Download Full-text